fibroblast

Cell therapyexperimental

A fibroblast is a type of biological cell typically with a spindle shape that synthesizes the extracellular matrix and collagen, produces the structural framework (stroma) for animal tissues, and plays a critical role in wound healing. Fibroblasts are the most common cells of connective tissue in animals. — Wikipedia

Clinical trial activity

5 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
3
Phase 3
1
Phase 4
0

Earliest trial started Sep 1, 2008 (NCT01115634)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • FibroblastsTissue restoration

    tissue restoration - fibroblasts

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • fibroblast
  • fibroblast

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03668028Phase 3Jul 9, 2018Seoul National University, Tego Science, Inc.
NCT03140319Phase 1/Phase 2 (Phase 2)Jul 10, 2017Tabriz Medical University
NCT01704209Phase 1Apr 1, 2013Northwestern University
NCT01874015Phase 1Feb 1, 2013Royan Institute
NCT01115634Phase 2Sep 1, 2008Royan Institute
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Royan InstituteAcademic/Hospital2222008
Northwestern UniversityAcademic/Hospital1112013
Seoul National UniversityAcademic/Hospital1012018
Tabriz Medical UniversityAcademic/Hospital1112017
Tego Science, Inc.For profit1112018
5 organizations
Page 1 / 1